„Bioabsorbable Stents Market Material (Polymer, Metal), Procedure (Invasive), Absorption Rate (Slow, Fast), Drugs (Limus Drugs, Paclitaxel), Application (CAD, PAD), End User (Hospital, Cardiac Centers) – Forecast to 2021 „ , published by MarketsandMarkets,
USD 2.4 Billion by 2021 from USD 0.4 Billion by 2016, at a CAGR of 42.5% from 2016 to 2021.
Browse 88 market data tables
43 Figures 126 Pages
and in-depth TOC on “ Bioabsorbable Stents Market „
The major driving factors are the increasing focus of the on clinical trials of bioabsorbable stents, increasing aging population, technological advances, and patients‘ preference for minimally invasive therapies.
However, factors such as the high prices of these stents may hamper the growth of the market.
In this report, the Bioabsorbable Stents Market is segmented on the basis of material, absorption rate, application, end user, and region. Based on material, the market is segmented into polymer stents, and metallic stents. The polymeric stents segment is expected to grow at the highest CAGR due to the various facts. These stents have a polymer coating of poly-D, L-lactide, which enables the controlled release of various drugs.
Speak to our research experts:
http://www.marketsandmarkets.com/speaktoanalyst.asp?id=40983380
By absorption rate, the market is sub-segmented into fast and slow bioabsorbable stents. In 2016, slow absorbable stents is expected to account for the largest share of the absorption rate. The growth in this segment is attributed to the slow duration of drug release within the arteries. This ensures efficient healing.
Geographically, the Bioabsorbable Stents Market is dominated by Europe, followed by North America. North American market is expected to grow at the highest CAGR of 46.1% during the forecast period. This growth can be attributed to the increase in aging population, unhealthy lifestyle habits, and the strong healthcare infrastructure in this market.
The bioabsorbable stent market has fewer numbers of players. Prominent players in the market include Abbott (U.S.), Elixir Medical Corporation (U.S.), Kyoto Medical Co. LTD. (Japan), Reva Medical Inc. (U.S.), Arterial Remodeling Technologies (France), Tepha Inc. (U.S.), Meril Life Sciences Pvt. Ltd. (India) among others.
Medical Devices Market Research Reports & Consulting
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the „Growth Engagement Model – GEM“. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write „Attack, avoid and defend“ strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets‘ flagship competitive intelligence and market research platform, ‚Knowledgestore‘, joins over 200,000 markets and entire value chains for deeper understanding of the unmet market along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets ™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
United States: 1-888-600-6441
sales@marketsandmarkets.com